We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-5.15%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
AUM
$242M
AUM Growth
-$27.8M
Cap. Flow
-$11.1M
Cap. Flow %
-4.59%
Top 10 Hldgs %
37.51%
Holding
109
New
14
Increased
27
Reduced
32
Closed
36

Sector Composition

Rank Sector Weight
1 Healthcare 87.52%
2 Financials 2.14%
3 Energy 0%
4 Industrials 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
101
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-26,040
Closed -$472K
TSRO
102
DELISTED
TESARO, Inc.
TSRO
-3,400
Closed -$341K
KERX
103
DELISTED
Keryx Biopharmaceuticals Inc
KERX
-116,000
Closed -$616K
VWR
104
DELISTED
VWR Corporation
VWR
-107,422
Closed -$3.05M
KITE
105
DELISTED
Kite Pharma, Inc.
KITE
-9,800
Closed -$547K
PRXL
106
DELISTED
Parexel International Corp
PRXL
-10,100
Closed -$701K
AMSG
107
DELISTED
Amsurg Corp
AMSG
-147,500
Closed -$9.89M
GI
108
DELISTED
EndoChoice Holdings, Inc.
GI
-121,663
Closed -$971K

Similar funds

Endurant Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Endurant Capital Management held 109 positions worth $242M, down 10% from $270M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Endurant Capital Management withdrew a net $11.1M in Q4 2016, closing 36 positions and reducing 32 holdings. Its most notable exit was Amsurg Corp, an estimated $9.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 87% a quarter earlier, followed by Financials and Energy.

Against the trend, Endurant Capital Management opened a new position in Pfizer worth $4.52M.

  • Endurant Capital Management's largest Q4 2016 buy was Pfizer: 146,611 shares worth $4.52M.
  • Endurant Capital Management added most to Becton Dickinson in Q4 2016, an estimated $7.67M increase.
  • Endurant Capital Management's biggest Q4 2016 reduction was Aetna Inc, cutting an estimated $5.01M.
  • Endurant Capital Management fully exited Amsurg Corp in Q4 2016, selling an estimated $9.89M.
  • Endurant Capital Management's ten largest holdings make up 38% of its $242M portfolio in Q4 2016.
  • Endurant Capital Management opened 14 new positions and closed 36 in Q4 2016.
  • Endurant Capital Management's portfolio value fell 10% quarter-over-quarter to $242M.

Based on Endurant Capital Management's 13F filing for Q4 2016, filed 15 Feb 2017.